CDC now investigating 180 cases of kids with acute hepatitis of unknown cause

CDC now investigating 180 cases of kids with acute hepatitis of unknown cause


The Centers for Disease Control and Prevention (CDC) headquarters in Atlanta, Georgia.

Tami Chappell | Reuters

The Centers for Disease Control and Prevention is now investigating 180 cases of children who suddenly developed severe hepatitis across 36 states and territories, an increase of 71 cases since the public health agency’s last update earlier this month.

The CDC, in a statement Wednesday, said the vast majority are not new cases of hepatitis. Rather, the number of patients under investigation have increased as the agency looks more closely at data that goes back to October of last year.

Hepatitis is an inflammation of the liver that is commonly caused by hepatitis viruses A, B, C, D and E. The cases the CDC is investigating are unusual because the children have not tested positive for those viruses and they have suffered severe symptoms, with 9% requiring liver transplants, which is rare.

The CDC has found at least five deaths, although no fatalities have been reported since February. Adenovirus infection is being investigated as being the possible cause, with nearly half the kids testing positive for the pathogen. Adenovirus is a common virus that normally causes cold or flu-like symptoms. It is not a known cause of hepatitis in otherwise healthy children.

The CDC also is conducting lab tests to see if the Covid virus might also be a possible cause, though the children in the initial cluster in Alabama did not have the coronavirus.

The United Kingdom first alerted the World Health Organization to severe cases of hepatitis in kids last month. The U.K. Health Security Agency, in an update last week, said adenovirus is the most commonly detected virus in the samples tested there. The country has identified 176 cases as of May 10.

The CDC said severe hepatitis in kids remains rare, but told parents to be on the look out for symptoms such as jaundice, which is yellowing of the skin or eyes.

CNBC Health & Science

Read CNBC’s latest global coverage of the Covid pandemic:



Source

2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market
Health

2026 is the year of obesity pills. Here’s how they could reshape the GLP-1 market

The booming GLP-1 space was built on weekly injections. In 2026, new obesity pills will push the market into its next chapter. Patients are already getting their hands on the first GLP-1 pill for obesity from Danish drugmaker Novo Nordisk — a once-daily drug that shares the same brand name as its popular injection Wegovy. […]

Read More
Healthy Returns: What to expect from pharma at the JPM conference
Health

Healthy Returns: What to expect from pharma at the JPM conference

Heidi Overton, Novo Nordisk CEO Maziar Mike Doustdar, Eli Lilly CEO David A. Ricks, and U.S. Secretary of Commerce Howard Lutnick listen while U.S. President Donald Trump announces a deal with Eli Lilly and Novo Nordisk on to reduce the prices of GLP-1 weight‑loss drugs during an event in the Oval Office at the White […]

Read More
A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year
Health

A little-known biotech stock has become a prime takeover target after surging nearly 1,700% last year

Europe’s best-performing blue-chip stock in 2025 is widely expected to be bought by a larger peer, in a deal analysts say could be worth as much as $23 billion. Abivax, the French clinical-stage biotech company developing a treatment for ulcerative colitis and Crohn’s disease, saw shares rocket 1,681% last year, far outpacing the Stoxx 600 […]

Read More